Spirulina and fertility: oxidative stress in gametes, male and female mechanisms, and IVF context

Oxidative stress as the shared mechanism

Both sperm and oocytes are exceptionally vulnerable to oxidative damage. Sperm plasma membranes are 60–70% polyunsaturated fatty acids — prime lipid peroxidation targets. Granulosa cells surrounding the oocyte generate ROS via NADPH oxidase and mitochondrial ETC as part of normal follicular function, but excess ROS damages oocyte spindle assembly and mitochondrial DNA.
Clinical evidence for antioxidant benefit in infertility: a Cochrane review of male factor infertility concluded that antioxidant supplementation may improve fertilisation rates and live birth rates. In female infertility, follicular fluid total antioxidant capacity (TAC) correlates with oocyte quality and IVF success across multiple clinical studies.

NOX5 and sperm ROS: Spermatozoa express NOX5 (not NOX2), which generates physiological ROS required for capacitation, hyperactivation, and the acrosome reaction. Excess NOX5 activity drives DNA fragmentation index (DFI) above 15% — the clinical threshold above which fertilisation rates decline. Phycocyanobilin’s NOX2 inhibition does not directly inhibit NOX5, but its radical scavenging action (tetrapyrrole π-electron system) reduces excess superoxide that propagates from NOX5 activity.
Lipid peroxidation protection: Phycocyanobilin and spirulina polyphenols reduce malondialdehyde (MDA) in seminal plasma. MDA from sperm membrane lipid peroxidation is a validated marker of oxidative male infertility. Studies in animal models show spirulina reduces testicular MDA and improves sperm parameters.
Zinc for testosterone and maturation: Zinc (0.5–1.5 mg/5 g spirulina) supports testosterone synthesis via 17β-hydroxysteroid dehydrogenase activity and epididymal sperm maturation. Seminal zinc concentration is depleted in men with oxidative infertility.
Iron for spermatogenesis: Iron is required for mitochondrial function during spermatogenesis and for ribonucleotide reductase in rapidly dividing spermatogonia. Iron deficiency impairs sperm production rate.

Granulosa cell NOX2: Granulosa cells generate ROS via NADPH oxidase. Physiological levels trigger oocyte meiotic resumption and ovulation. Excess ROS damages oocyte spindle assembly, zona pellucida proteins, and mitochondrial DNA. Phycocyanobilin inhibits NOX2 in granulosa cells, reducing excess oxidative burden while preserving physiological ROS.
Iron for ovarian function: Iron deficiency impairs thyroxine peroxidase (thyroid function is essential for ovulation) and ribonucleotide reductase in rapidly dividing granulosa cells. Iron deficiency is extremely common in women of reproductive age (particularly in those with heavy periods or vegetarian/vegan diets).
PCOS — insulin sensitisation: Spirulina’s adiponectin-increasing and insulin-sensitising effects reduce hyperinsulinaemia in PCOS, which normalises LH pulsatility and reduces ovarian androgen overproduction — the primary barrier to follicular development and ovulation in PCOS.

Ovarian stimulation for IVF creates supraphysiological oxidative load in multiple follicles simultaneously. Antioxidant supplementation before and during stimulation is increasingly recommended in poor responders and women over 35 by reproductive endocrinologists.
No pharmacokinetic interaction between spirulina and gonadotropins (FSH, LH, hCG). No interaction with GnRH agonists (leuprorelin, buserelin) or antagonists (cetrorelix, ganirelix). Spirulina can be continued during IVF stimulation as an antioxidant adjunct. Inform your IVF clinic before starting any supplement during an active cycle.
Suggested timing in IVF context: begin 3–5 g/day at least 60 days before egg collection (the duration of follicular development) to allow accumulation of antioxidant benefit in follicular fluid.

Male factor infertility: 3–5 g/day; allow 74 days (full spermatogenesis cycle) before reassessing sperm parameters
Female factor — general: 3–5 g/day; check ferritin and transferrin saturation; correct iron deficiency alongside spirulina
PCOS: 3–5 g/day; the insulin-sensitising mechanism is the strongest evidence-based rationale; complementary to metformin and letrozole
IVF preparation: 3–5 g/day starting 60+ days before egg collection; no interaction with stimulation medications; inform clinic
No phytoestrogenic activity in spirulina — safe alongside clomiphene, letrozole, and HRT without oestrogen-modulating risk